Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Heart Failure Reports
Published in: Current Heart Failure Reports 2/2009

01-06-2009

The brain renin-angiotensin-aldosterone system: A major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction

Authors: Bing S. Huang, Frans H. H. Leenen

Published in: Current Heart Failure Reports | Issue 2/2009

Login to get access
Metadata
Title
The brain renin-angiotensin-aldosterone system: A major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction
Authors
Bing S. Huang
Frans H. H. Leenen
Publication date
01-06-2009
Publisher
Current Science Inc.
Published in
Current Heart Failure Reports / Issue 2/2009
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-009-0013-9

Other articles of this Issue 2/2009

Current Heart Failure Reports 2/2009 Go to the issue

OriginalPaper

Insulin resistance and heart failure

OriginalPaper

Nitric oxide regulation of autonomic function in heart failure

OriginalPaper

Should aldosterone blockade be used beyond current indications in heart failure?

OriginalPaper

Respiratory muscle function and exercise intolerance in heart failure

OriginalPaper

Pharmacologic management of the cardiorenal syndrome in heart failure

OriginalPaper

Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: How much is too much?
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits